JPS58140015A - L-ascorbic acid administered in powdery form - Google Patents

L-ascorbic acid administered in powdery form

Info

Publication number
JPS58140015A
JPS58140015A JP2177982A JP2177982A JPS58140015A JP S58140015 A JPS58140015 A JP S58140015A JP 2177982 A JP2177982 A JP 2177982A JP 2177982 A JP2177982 A JP 2177982A JP S58140015 A JPS58140015 A JP S58140015A
Authority
JP
Japan
Prior art keywords
ascorbic acid
sugar
mixed
amount
stevioside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2177982A
Other languages
Japanese (ja)
Inventor
Hiroo Takashima
広雄 高島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2177982A priority Critical patent/JPS58140015A/en
Publication of JPS58140015A publication Critical patent/JPS58140015A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:L-Ascorbic acid, obtained by incorporating fine powdery sugar prepared from stevioside with L-ascorbic acid, and administrable with a nice taste and reduced sourness without solidifying even on storing under bad conditions for a long term due to the suppressed deliquescence. CONSTITUTION:L-Ascorbic acid obtained by incorporating 0.05wt% or more, preferably 0.1-0.5wt%, fine powdery sugar prepared from stevioside with L- ascorbic acid. The L-ascorbic acid of high purity near 100% can be administered without giving an adverse effect to the human body because an additional chemical other than the sweetening agent need not be mixed and the amount of the sugar is very small.

Description

【発明の詳細な説明】 本発明は、粉末状であって水に溶解して飲むL−アスコ
ルビン酸に関し、特に水に溶解し易くて美味なL−アス
コルビン酸に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to L-ascorbic acid which is in powder form and is dissolved in water for drinking, and particularly relates to L-ascorbic acid which is easily dissolved in water and is delicious.

■ 先行技術 L−アスコルビン酸は人体に不可欠のビタミンで、この
ビタミンが欠乏すると壊血病になる。
■ Prior art L-ascorbic acid is an essential vitamin for the human body, and a deficiency of this vitamin results in scurvy.

し−アスコルビン酸は粉末状の結晶で水に溶は易い為、
これを水に溶解することによって雄れもが簡単に服用で
きる。しかしなから、L−アスコルビン酸は飽和水溶液
の示す水蒸気[→−が、大気中の水蒸気圧に比べて著し
く低い為、結晶が大気中の水分を吸収してしだいに溶解
してい〈潮解性を有する。この為、粉末が空気中の水分
を吸収して部分的に固まりを生じ易く、シかも固1り状
に固結すると水に溶解し鑓くなる欠1点があった。
Ascorbic acid is a powdered crystal that easily dissolves in water.
Males can be easily taken by dissolving this in water. However, since the water vapor [→-] of a saturated aqueous solution of L-ascorbic acid is significantly lower than the water vapor pressure in the atmosphere, the crystals absorb moisture from the atmosphere and gradually dissolve (deliquescent). have For this reason, the powder tends to absorb moisture in the air and partially clump, and if it clumps into a lump, it dissolves in water and becomes flaky.

L−アスコルビン酸の潮解性は、製の工程に於て本数々
の弊害を生ずる。例えばこれを0.3〜数gに区分して
密封する工程に於ても、密封されるまでの間に、空気中
の水分を吸収して固化し易く、又固化すると正確に計量
して区分けするのが難しく、計量誤差を生ずると共に、
商品価値が著しく低下した。
The deliquescent nature of L-ascorbic acid causes a number of problems in the manufacturing process. For example, even in the process of dividing this into 0.3 to several grams and sealing it, it is easy to absorb moisture in the air and solidify until it is sealed, and once it solidifies, it must be accurately weighed and divided. It is difficult to do this, causing measurement errors, and
Product value has decreased significantly.

又、アスコルビン酸は極めて酸味の強い粉末で、これを
水に溶解しただけでは酸っばくて美味に服用できない。
Furthermore, ascorbic acid is an extremely sour powder, and if it is simply dissolved in water, it will be so sour that it cannot be taken deliciously.

この為、従来はこれにサッカロースを混合して甘味を加
えて服用した。
For this reason, it has traditionally been mixed with saccharose to give it a sweet taste.

L−アスコルビン酸に添加されるサッカロースとして、
甘しょ糖やてん菜糖が使用された。しかしながら、これ
等のサッカロースが添加されたし一7スコルビン酸は、
L−アスコルビン酸特有の潮解性を有し、長期間に渡っ
て粉末状に保持し難い欠点があった。
As sucrose added to L-ascorbic acid,
Cane sugar and beet sugar were used. However, these sucrose-added and 17-scorbic acids
It has a deliquescent property unique to L-ascorbic acid, and has the disadvantage that it is difficult to maintain it in powder form for a long period of time.

■ 目的 本発明は、L−アスコルビン酸特有の潮解性を抑制して
、悪条件下に長期間保存されても固化せず、しかもこの
潮解性を阻止する添加剤が、L−アスコルビン酸の酸味
を少なくして美味に服用する為の添加剤を兼用する為、
潮解性を阻止する為の添加剤と甘味料の両者を混合する
必要がなく、艷に、ステビアサイトから製造された砂糖
は、甘しょ糖やてん菜糖に比べて甘味が極めて強く、混
合量を極減してほとんど100%純度のL−アスコルビ
ン酸で服用でき、更に又、ステビアサイトの甘味は、高
純度の甘しょ糖やてん菜糖に近い味を有し、酸味の強い
し一アスコルビン酸を著しく美味にできる粉末状で服用
するし一アスコルビン酸を提供するにある。
■Purpose The present invention suppresses the deliquescent property peculiar to L-ascorbic acid so that it does not solidify even when stored under adverse conditions for a long period of time. Because it also serves as an additive to reduce the amount of alcohol and make it more delicious to take,
There is no need to mix both additives and sweeteners to prevent deliquescence, and sugar made from steviasite is extremely sweet compared to cane sugar or beet sugar, making it possible to minimize the amount of sugar mixed. Steviasite can be taken with almost 100% pure L-ascorbic acid, and the sweetness of steviasite is similar to that of high-purity cane sugar or beet sugar. It can be taken in powder form and provides ascorbic acid.

■ 構成 以下本発明の実施例を脱血する。■ Configuration Below, examples of the present invention will be exsanguinated.

L−アスコルビン酸は粉末結晶で、これにステビアサイ
トから製造された微粉末状の砂糖が混合される。
L-ascorbic acid is a powdered crystal to which finely powdered sugar made from steviasite is mixed.

砂糖の混合量は、潮解性による固化防f1−.と、服用
時の甘味とを考慮して最適値に決定する。
The amount of sugar mixed is determined to prevent solidification due to deliquescent property f1-. The optimal value is determined by taking into consideration the sweetness and sweetness at the time of administration.

砂糖の混合量が少なすぎると、L−アスコルビン酸特有
の酸味が強くて甘味のある美味なものとできず、また、
L−アスコルビン酸の潮解性によって固化し易くなる。
If the amount of sugar mixed is too small, the sourness characteristic of L-ascorbic acid will not be strong, sweet and delicious, and
The deliquescent nature of L-ascorbic acid makes it easy to solidify.

反対に、砂糖の混合量が多すぎると、空気中の水分によ
って固化するのは防止できるが、甘味が強すぎて美味に
服用し得ない。
On the other hand, if too much sugar is mixed, it will prevent solidification due to moisture in the air, but the sweetness will be too strong and it will not be delicious to take.

酸味を抑制して服用に供し得ることができ、又潮解性に
よる同化を阻止し得る為に、L−アスコルビン酸に添加
される砂糖の最低量は、重量比で、0.05%以上好ま
しくは0.1%以りである。
The minimum amount of sugar added to L-ascorbic acid is preferably 0.05% or more by weight, in order to suppress the sour taste and make it available for administration, and to prevent assimilation due to deliquescent properties. It is 0.1% or more.

砂糖の混合の最大値は、砂糖の甘味によって制限される
が、通常は重量比で5%以下、好ましくは0.5%以下
に決定される。
The maximum amount of sugar mixed is limited by the sweetness of the sugar, but is usually determined to be 5% or less, preferably 0.5% or less by weight.

L−アスコルビン酸に、ステビアサイトを原料とする砂
糖を混合するには、例えば1000gのL−アスコルビ
ン濠に、1〜3gの砂糖を混合し、これを攪拌するだけ
でよい。
In order to mix L-ascorbic acid with sugar made from steviasite, it is sufficient to mix, for example, 1 to 3 g of sugar with 1000 g of L-ascorbic acid and stir the mixture.

L−アスコルビン酸に混合された砂糖は、その粒子が結
晶したL−アスコルビン酸に比べて充分に小さく、L−
アスコルビン酸の表面に付着される。
The sugar mixed with L-ascorbic acid has particles that are sufficiently small compared to crystallized L-ascorbic acid,
Ascorbic acid is attached to the surface.

■ 効果 本発明のL−アスコルビン酸がいかに優れた特性を実現
するかを数値で示すことは値しい。この為、本発明者は
外的条件、特に、湿度と温度とを一定にして、L−アス
コルビン酸の固化状態がどのように変化するかを、従来
のしよ糖が混合されたものと比較して実測した。その結
果が表に示されている。
(2) Effects It is worthwhile to numerically demonstrate how the L-ascorbic acid of the present invention achieves excellent properties. For this reason, the present inventor held constant external conditions, especially humidity and temperature, and compared how the solidification state of L-ascorbic acid changes with that of a conventional product mixed with sucrose. I actually measured it. The results are shown in the table.

この表に於て、 0は全く固化を発生しなかったもの、 △は多少固化を生じたがこれを容器内に収納して振ると
ほとんどの固まりが分散できたもの、×多くの固まりを
生じ、しかもこの固まりが容器に入れて振っても充分に
分散できなかったもの、 この表は、開封されたL−アスフルビン酸ニ所定量の砂
糖を混合した後、温度と湿度とが一定範囲に制限された
気密室に収納し、その後36時間経過後の状態を目測し
た。
In this table, 0 indicates that no solidification occurred at all, △ indicates that some solidification occurred, but when the container was placed in a container and shaken, most of the solids were dispersed, and × many solids occurred. , Moreover, this lump could not be sufficiently dispersed even if it was placed in a container and shaken. This table shows that after opening the package L-asfulvic acid and mixing the specified amount of sugar, the temperature and humidity are limited to a certain range. The specimen was stored in an airtight room, and the condition was visually observed 36 hours later.

気密室内に収納される砂糖混合のL−アスコルビン酸は
、全体量を1gとし、これを合成樹脂シートの上に約3
0cdの広さに均一に拡げて収納した。
The total amount of sugar-mixed L-ascorbic acid stored in an airtight room is 1 g, and about 3 g of this is placed on a synthetic resin sheet.
It was spread uniformly over an area of 0 cd and stored.

なお、気密室内の温度離設定値から10.5℃の範囲内
に温度制御し、湿度はL−アスコルビン階収納直後の値
で、その後湿度を一定に保持する手段は使用していない
が、気密室の容積が約502と相対に大きい為か、36
時間経過後もその値はほとんど変化しなかった。
The temperature was controlled within a range of 10.5°C from the set temperature in the airtight room, and the humidity was the value immediately after storage on the L-ascorbine floor, and no means to maintain a constant humidity was used after that. Perhaps because the volume of the closed room is relatively large at approximately 502, 36
The value hardly changed after the passage of time.

、 また、従来品の代表例として、甘しょ糖を混合した
L−アスコルビン酸は、これが美味に服用できるように
、甘しょ糖の混合率を59wt%とじた。
In addition, as a typical example of a conventional product, L-ascorbic acid mixed with cane sugar has a sugar content of 59 wt% so that it can be taken deliciously.

この表からも明らかなように、本発明の飲用り一アスコ
ルビンI!!は、甘しょ糖に比べて著しく少量の砂糖を
加えるだけで、し−アスコルビン酸独特の潮解性による
固まりを防止し、保存並びド製造工程に於ける外的条件
が悪くとも、長時間に渡ってサラサラとした粉末状を保
持する特長を実現する。
As is clear from this table, the drinking product of the present invention, Ascorbine I! ! By adding a significantly smaller amount of sugar than cane sugar, ascorbic acid's unique deliquescent properties prevent it from clumping, allowing it to remain stable for long periods of time even under adverse external conditions during storage and manufacturing processes. Achieves the characteristic of maintaining a smooth powder form.

又、L−アスコルビン酸の固化を、甘味の強いステビア
サイトの砂糖で防止する為、砂糖が固まり防止剤と甘味
料とを兼用し、甘味料以外に余分な薬剤を混合する必要
がなく、又固化を防止する薬剤が砂糖であってしかもこ
れが微量の為、これが人体に悪影響を与えることがなく
、更に又、砂糖の混合量が微量で100%近い高純度の
し一アスフルビン酸が服用できる卓効を実現する。
In addition, since the solidification of L-ascorbic acid is prevented by the highly sweet steviasite sugar, the sugar acts both as an anti-caking agent and a sweetener, eliminating the need to mix in any extra chemicals other than the sweetener. The drug that prevents solidification is sugar, and since it is in a very small amount, it does not have any negative effects on the human body.Furthermore, it is possible to take almost 100% pure asfulvic acid with only a very small amount of sugar mixed in. achieve effectiveness.

又、本発明の粉末状し一アスコルビン酸が付着性少なく
、常にサラサラとして粉末であることは次の実験によっ
ても明らかとなった。
Further, the following experiment also revealed that the powdered monoascorbic acid of the present invention has little adhesion and is always smooth and powdery.

ステビアサイトを原料とする砂糖がQ、3wt%混合さ
れた本発明のL−アスコルビン酸と、甘しょ糖が59w
t%混合された従来のし一アスコルビン酸とを、1g容
積の小さじですくい、小さじですくい取ることができる
最大量を計量したと10%も少なくなった。本発明品が
少ないのは、さじの上に高く盛り上った状態ですくうこ
とができず、サラサラとより多くすべり落ちたことに起
因する。
The L-ascorbic acid of the present invention is mixed with Q, 3 wt% of sugar made from steviasite, and 59 w of cane sugar.
When we scooped up 1 g of conventional silica-ascorbic acid mixed with 1 g of ascorbic acid and measured the maximum amount that could be scooped out with the teaspoon, it was 10% less. The reason why there are so few products of the present invention is because they cannot be scooped up high on a spoon, and more of them slide down smoothly.

このことからも、本発明のし一アスコルビン酸が、いか
にサラサラした状態を保持できるかが証明された。
This also proves how the ascorbic acid of the present invention can maintain a smooth state.

なお、さじですくい取られたし一アスコルビン酸は、両
番とも、混合した後、湿度75%、温度25℃の環境に
開口面積が49〜の容器に収納して12時間放置し、そ
の表面付近のL−アスコルビン酸をさじですくい取って
重量を計測した。
After mixing the ascorbic acid scooped out with a spoon, the ascorbic acid was stored in a container with an opening area of 49°C for 12 hours in an environment with a humidity of 75% and a temperature of 25°C. The nearby L-ascorbic acid was scooped out with a spoon and the weight was measured.

Claims (2)

【特許請求の範囲】[Claims] (1)  ステビアサイトから製造された微粉状の砂糖
が混合されたことを特長とする粉末で服用するL−アス
コルビン酸。
(1) L-ascorbic acid taken in powder form, characterized by being mixed with finely powdered sugar produced from steviasite.
(2)砂糖の混合量が重量比で0.1〜5%である特許
請求の範囲第(1)項記載の粉末状で服用するL−アス
コルビン酸。
(2) L-ascorbic acid to be taken in powder form according to claim (1), wherein the amount of sugar mixed is 0.1 to 5% by weight.
JP2177982A 1982-02-13 1982-02-13 L-ascorbic acid administered in powdery form Pending JPS58140015A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2177982A JPS58140015A (en) 1982-02-13 1982-02-13 L-ascorbic acid administered in powdery form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2177982A JPS58140015A (en) 1982-02-13 1982-02-13 L-ascorbic acid administered in powdery form

Publications (1)

Publication Number Publication Date
JPS58140015A true JPS58140015A (en) 1983-08-19

Family

ID=12064542

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2177982A Pending JPS58140015A (en) 1982-02-13 1982-02-13 L-ascorbic acid administered in powdery form

Country Status (1)

Country Link
JP (1) JPS58140015A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152327A (en) * 1983-02-16 1984-08-31 Otsuka Pharmaceut Co Ltd Stabilized vitamin preparation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5088269A (en) * 1973-12-05 1975-07-15
JPS51142570A (en) * 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent
JPS53101518A (en) * 1977-02-17 1978-09-05 Merck Patent Gmbh Production of ascorbinic acid containing minute particle

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5088269A (en) * 1973-12-05 1975-07-15
JPS51142570A (en) * 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent
JPS53101518A (en) * 1977-02-17 1978-09-05 Merck Patent Gmbh Production of ascorbinic acid containing minute particle

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152327A (en) * 1983-02-16 1984-08-31 Otsuka Pharmaceut Co Ltd Stabilized vitamin preparation
JPH0337521B2 (en) * 1983-02-16 1991-06-05 Otsuka Pharma Co Ltd

Similar Documents

Publication Publication Date Title
EP0325790B1 (en) Low-caloric sweetening composition of microcrystalline appearance
US4886677A (en) Surface-modified meso-erythritol composition
US10315974B2 (en) Crystalline maltitol powder less prone to consolidation and method for production thereof
US2851359A (en) Effervescive powders for producing protracted ebullition
US2879161A (en) Stable dry powder compositions containing choline chloride and methods of preparing same
US2971851A (en) Scavenger packet
US5725795A (en) Oxygen absorber and method for producing same
JPS58140015A (en) L-ascorbic acid administered in powdery form
US2208120A (en) Pharmaceutical preparation and method of making same
JPH05137535A (en) Fine crystal-containing sweetening agent composition having fluidity
CA2601242C (en) Granular sucralose, and method of making it
US3965263A (en) Choline salicylate compositions and methods for achieving analgesia
JP2517862B2 (en) How to prevent salt solidification
JP2635274B2 (en) Bittern-containing edible salt
US3374098A (en) Flake salt made free-flowing by applying propylene glycol to the salt particle surfaces
US3512929A (en) Flowable ammonium thiosulfate and method for its manufacture
JPH057983B2 (en)
JP2517853B2 (en) How to prevent salt solidification
JP2000233923A (en) Method for preventing solidification of salt
US1535525A (en) Spray mixture and process of making the same
JPH0276868A (en) Production of stable sodium ascorbate composition and powder
Machkovech et al. Deliquescent behavior of a prostaglandin
WO1990007338A1 (en) Calcium chloride containing preparation for the prevention or the treatment of hypocalcemia in ruminants
JPH01102073A (en) Stabilized ascorbic acid powder and its production
JPH0195741A (en) Low-calorie sweetener composition having appearance of crystallite state